NEW YORK (GenomeWeb) – Infectious disease diagnostics firm DNAe today announced a bank facility of £25 million ($38.7 million) from Citibank, to fund the development of its point-of-care diagnostics for septic infections. The firm said it expects to conduct clinical trials in 2016 and launch its product in 2017. The funds will help DNAe finish its attempt to integrate its Genalysis DNA sequencing technology with its subsidiary DNA Electronics' Pathogen Capture System to create a blood test for serious infections that provides results in two to three hours, the firm said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.